收费全文 | 8342篇 |
免费 | 497篇 |
国内免费 | 20篇 |
2024年 | 14篇 |
2023年 | 98篇 |
2022年 | 268篇 |
2021年 | 421篇 |
2020年 | 390篇 |
2019年 | 585篇 |
2018年 | 462篇 |
2017年 | 319篇 |
2016年 | 428篇 |
2015年 | 452篇 |
2014年 | 578篇 |
2013年 | 732篇 |
2012年 | 694篇 |
2011年 | 677篇 |
2010年 | 368篇 |
2009年 | 305篇 |
2008年 | 334篇 |
2007年 | 353篇 |
2006年 | 298篇 |
2005年 | 243篇 |
2004年 | 186篇 |
2003年 | 151篇 |
2002年 | 129篇 |
2001年 | 24篇 |
2000年 | 19篇 |
1999年 | 26篇 |
1998年 | 23篇 |
1997年 | 25篇 |
1996年 | 17篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 13篇 |
1992年 | 9篇 |
1991年 | 17篇 |
1989年 | 12篇 |
1988年 | 6篇 |
1987年 | 15篇 |
1986年 | 19篇 |
1985年 | 14篇 |
1984年 | 17篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1971年 | 5篇 |
1970年 | 5篇 |
Non-albicans Candida species and other rare yeasts have emerged as major opportunistic pathogens in fungal infections. Identification of opportunistic yeasts in developing countries is mainly performed by phenotypic assay, which are time-consuming and prone to errors. The aim of the present study was to evaluate PCR-RFLP as a routinely used identification technique for the most clinically important Candida species in Iran and make a comparison with a novel multiplex PCR, called 21-plex PCR. One hundred and seventy-three yeast isolates from clinical sources were selected and identified with sequence analysis of the D1/D2 domains of rDNA (LSU rDNA) sequencing as the gold standard method. The results were compared with those obtained by PCR-RFLP using MspI restriction enzyme and the 21-plex PCR. PCR-RFLP correctly identified 93.4% of common pathogenic Candida species (C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and P. kudriavsevii (=?C. krusei)) and was able to identify 45.5% of isolates of the uncommon yeast species compared to the D1/D2 rDNA sequencing. Compared with PCR-RFLP, all common Candida species and 72.7% of uncommon yeast species were correctly identified by the 21-plex PCR. The application of the 21-plex PCR assay as a non-sequence-based molecular method for the identification of common and rare yeasts can reduce turnaround time and costs for the identification of clinically important yeasts and can be applied in resource-limited settings.
相似文献In the present study, radiation doses and cancer risks resulting from abdominopelvic radiotherapy planning computed tomography (RP-CT) and abdominopelvic diagnostic CT (DG-CT) examinations are compared. Two groups of patients who underwent abdominopelvic CT scans with RP-CT (n = 50) and DG-CT (n = 50) voluntarily participated in this study. The two groups of patients had approximately similar demographic features including mass, height, body mass index, sex, and age. Radiation dose parameters included CTDIvol, dose–length product, scan length, effective tube current, and pitch factor, all taken from the CT scanner console. The ImPACT software was used to calculate the patient-specific radiation doses. The risks of cancer incidence and mortality were estimated based on the BEIR VII report of the US National Research Council. In the RP-CT group, the mean ± standard deviation of cancer incidence risk for all cancers, leukemia, and all solid cancers was 621.58 ± 214.76, 101.59 ± 27.15, and 516.60 ± 189.01 cancers per 100,000 individuals, respectively, for male patients. For female patients, the corresponding risks were 742.71 ± 292.35, 74.26 ± 20.26, and 667.03 ± 275.67 cancers per 100,000 individuals, respectively. In contrast, for DG-CT cancer incidence risks were 470.22 ± 170.07, 78.23 ± 18.22, and 390.25 ± 152.82 cancers per 100,000 individuals for male patients, while they were 638.65 ± 232.93, 62.14 ± 13.74, and 575.73 ± 221.21 cancers per 100,000 individuals for female patients. Cancer incidence and mortality risks were greater for RP-CT than for DG-CT scans. It is concluded that the various protocols of abdominopelvic CT scans, especially the RP-CT scans, should be optimized with respect to the radiation doses associated with these scans.
相似文献